A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment

Clinical trial NCT01448707 · COMPLETED

Trial details

NCT number: NCT01448707
Sponsor: Janssen-Cilag International NV
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV) Infections Acquired Immunodeficiency Syndrome (AIDS) Virus

Start date: 2012-03-15
Primary completion: 2014-06-11
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.